146.14
price down icon0.46%   -0.68
 
loading

Johnson & Johnson (JNJ) Stock Split History

Johnson & Johnson has split its stock 6 times since its initial public offering (IPO). The first stock split occurred on May 18, 1970 with the ratio of 3-for-1, meaning that for 1 share of JNJ owned pre-split, shareholders then owned 3 shares. 5 more splits have been implemented since then. The most recent stock split took place on June 13, 2001 on a 2-for-1 basis.

These splits have increased JNJ stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that these actions only change the number of shares and the price per share with no impact on Johnson & Johnson's total market capitalization.

For more detailed information of Johnson & Johnson's stock splits, view the table below:

JNJ stock split list

Date Split Ratio
2001-06-13 2 - for - 1
1996-06-12 2 - for - 1
1992-06-10 2 - for - 1
1989-05-11 2 - for - 1
1981-05-19 3 - for - 1
1970-05-18 3 - for - 1

Will Johnson & Johnson Stock Split in 2024?

The answer will depend on the decisions of the company's managers and market volatility. Johnson & Johnson has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when JNJ stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Johnson & Johnson's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.

Stock Splits of Industry Leaders

Ticker Symbol Latest Split Date Split Ratio
LLY 1997-10-16 2 - for - 1
JNJ 2001-06-13 2 - for - 1
MRK 1999-02-17 2 - for - 1
AZN 2015-07-27 2 - for - 1
NVS 2000-05-11 2 - for - 1
AMGN 1999-11-22 2 - for - 1
PFE 1999-07-01 3 - for - 1
BMY 1999-03-01 2 - for - 1
GSK 2022-07-22 4 - for - 5
GILD 2013-01-28 2 - for - 1
BIIB 2001-01-18 3 - for - 1
GRFS 2016-01-04 2 - for - 1
AMRN 2008-01-18 1 - for - 10
SCLX 2010-05-07 1 - for - 10
drug_manufacturers_general MRK
$131.20
price up icon 0.37%
$159.62
price down icon 4.58%
drug_manufacturers_general NVS
$97.44
price down icon 1.64%
$269.98
price up icon 0.22%
drug_manufacturers_general PFE
$25.40
price up icon 0.55%
Cap:     |  Volume (24h):